Syntara Limited (ASX:SNT)
0.0540
+0.0030 (5.88%)
At close: Apr 24, 2025, 4:00 PM AEST
Syntara Revenue
Syntara had revenue of 1.51M AUD in the quarter ending December 31, 2024. This brings the company's revenue in the last twelve months to 8.16M, up 31.15% year-over-year. In the fiscal year ending June 30, 2024, Syntara had annual revenue of 5.76M, down -7.51%.
Revenue (ttm)
8.16M
Revenue Growth
+31.15%
P/S Ratio
10.75
Revenue / Employee
388.33K
Employees
21
Market Cap
87.71M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Jun 30, 2024 | 5.76M | -468.00K | -7.51% |
Jun 30, 2023 | 6.23M | -9.52M | -60.45% |
Jun 30, 2022 | 15.76M | -7.87M | -33.31% |
Jun 30, 2021 | 23.63M | 11.01M | 87.28% |
Jun 30, 2020 | 12.62M | 444.00K | 3.65% |
Jun 30, 2019 | Pro | Pro | Pro |
Jun 30, 2018 | Pro | Pro | Pro |
Jun 30, 2017 | Pro | Pro | Pro |
Jun 30, 2016 | Pro | Pro | Pro |
Jun 30, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
CSL Limited | 24.61B |
Pro Medicus | 184.58M |
Cochlear | 2.31B |
Sonic Healthcare | 9.33B |
Telix Pharmaceuticals | 783.21M |
Ramsay Health Care | 17.12B |
Ansell | 3.00B |
Mesoblast | 9.16M |